These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6069635)

  • 1. Clinical trial with tolazamide, a new hypoglycemia agent; its potency compared to chlorpropamide.
    Quismorio FT; Villadolid LS; Egay LM; Wico AR; Llamas SP; Acurantes AI
    Acta Med Philipp; 1967; 3(4):261-5. PubMed ID: 6069635
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood glucose and drug levels in normal fasting subjects following single oral doses of tolazamide and chlorpropamide.
    Novak E; Borden K; Vitti T; Hearron M
    Mich Med; 1969 Dec; 68(24):1243-5. PubMed ID: 4901022
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypoglycemic drugs.
    Stehling L
    Clin Anesth; 1974; 10(1):233-47. PubMed ID: 4598996
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of oral hypoglycemic agents. VI. Comparative study on acute oral overload using tolbutamide and tolazamide in normal and diabetic subjects. Various aspects of the prolonged use of tolazamide in comparison with other sulfonylureas].
    Pereira VG; Wajchenberg BL; Shnaider J
    Arq Bras Endocrinol Metabol; 1965 Aug; 14(2):133-42. PubMed ID: 5322747
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypoglycemia caused by oral antidiabetic agents].
    de Baere H; Decraene P; de Leeuw I; Lemmens P; Verhaegen H
    Ned Tijdschr Geneeskd; 1973 Jul; 117(27):1021-4. PubMed ID: 4206176
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of sulphonylureas (tolazamide, tolbutamide and chlorpropamide) on the metabolism of diphenylhydantoin in the rat.
    Wesseling H; Thurkow I; Mulder G
    Biochem Pharmacol; 1973 Dec; 22(23):3033-40. PubMed ID: 4761563
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tolazamide in the control of diabetes mellitus].
    Ramos JV
    Prensa Med Mex; 1969; 34(1):66-7. PubMed ID: 5787505
    [No Abstract]   [Full Text] [Related]  

  • 8. Factors moderating the effect of oral sulfonylureas on free water clearance.
    Davis FB; Boh DM; Davis PJ; van Son AR; Mylotte KM; Edwards L; Zielezny M; Sczupak C
    J Clin Pharmacol; 1982; 22(2-3):97-101. PubMed ID: 7068939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe hypoglycemia reactions following treatment with tolbutamide, carbutamide and chlorpropamide (report on 14 cases, studies on clinical symptoms and pathogenesis)].
    Schulz E
    Arch Klin Med; 1968; 214(2):135-62. PubMed ID: 5718735
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of some hypoglycemic drugs on kinetics of potassium in the blood serum and in erythrocytes of healthy persons and in diabetic patients].
    Kinalska I; Stasikiewicz J
    Pol Tyg Lek; 1965 Jul; 20(27):1008-10. PubMed ID: 5840154
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of chronic liver disease due to tolazamide.
    Nakao NL; Gelb AM; Stenger RJ; Siegel JH
    Gastroenterology; 1985 Jul; 89(1):192-5. PubMed ID: 4007403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolazamide-induced cholestasis.
    Bridges ME; Pittman FE
    South Med J; 1980 Aug; 73(8):1072-4. PubMed ID: 7403921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on a new antidiabetic agent, glibenclamide (HB419). A clinical evaluation and comparative study.
    Potitong B
    J Med Assoc Thai; 1971 May; 54(5):329-34. PubMed ID: 4996291
    [No Abstract]   [Full Text] [Related]  

  • 14. Diuretic action of three sulfonylurea drugs.
    Moses AM; Howanitz J; Miller M
    Ann Intern Med; 1973 Apr; 78(4):541-4. PubMed ID: 4632790
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets.
    Del Guerra S; Marselli L; Lupi R; Boggi U; Mosca F; Benzi L; Del Prato S; Marchetti P
    J Diabetes Complications; 2005; 19(1):60-4. PubMed ID: 15642492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man.
    Jankowski A; Wichliński LM; Bokowski W; Romański B
    Pol J Pharmacol Pharm; 1984; 36(5):449-53. PubMed ID: 6533629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies on hypoglycemic sulphonylureas.
    Khurana U; Anantnarayanan KG; Panse MV
    Indian J Med Res; 1967 Oct; 55(10):1084-91. PubMed ID: 5594382
    [No Abstract]   [Full Text] [Related]  

  • 18. [Suicide by means of oral antidiabetics (sulfonylurea products)].
    Schulz E; Börner H
    Munch Med Wochenschr; 1966 Apr; 108(17):961-5. PubMed ID: 6014225
    [No Abstract]   [Full Text] [Related]  

  • 19. A clinical evaluation of the comparative effectiveness of chlorpropamide and acetohexamide.
    Fox OJ; Boshell BR; DiPlacido J
    J Med Assoc State Ala; 1968 Apr; 37(10):1155-9. PubMed ID: 5650590
    [No Abstract]   [Full Text] [Related]  

  • 20. The use and abuse of oral hypoglycemic agents.
    Sussman KE
    Rocky Mt Med J; 1967 Feb; 64(2):56-9. PubMed ID: 6045352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.